Barrett's Surveillance Identifies Patients with Early Esophageal Adenocarcinoma

American Journal of Medicine

Volumn 123, Issue 5, 2010, Pages 462-467

  Wong, Timothy ^a   Tian, Jianmein ^b   Nagar, Anil Bernard ^c,d  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; High grade dysplasia; Low grade dysplasia; Surveillance; Upper endoscopy

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DISEASE SURVEILLANCE; DYSPLASIA; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; HEALTH CARE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 77950620441     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.10.013     Document Type: Article

References (35)

1. Blot W.J., and McLaughlin J.K. The changing epidemiology of esophageal cancer. Semin Oncol 26 (1999) 2-8
2. Pohl H., and Welch H.G. The role over diagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97 (2005) 142-146
3. Want K.K., Wongkeesong M., and Buttar N.S. American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 128 (2005) 1471-1505
4. Cameron A.J., Ott B.J., and Payne W.S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313 (1985) 857-859
5. Ruol A., Parenti A., Zaninotto G., et al. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 88 (2000) 2520-2528
6. Mueller J., Werner M., and Siewert J.R. Malignant progression in Barrett's esophagus: pathology and molecular biology. Recent Results Cancer Res 155 (2000) 29-41
7. Corley D.A., Levin T.R., Habel L.A., et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 122 (2002) 633-640
8. Van Sandick J.W., van Lanschot J.J., Kuiken B.W., et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 43 (1998) 216-222
9. Wright T.A., Gray M.R., Morris A.I., et al. Cost effectiveness of detecting Barrett's cancer. Gut 39 (1996) 574-579
10. Wang K.K., and Sampliner R.E. Updated guidelines 2008 for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 103 (2008) 788-797
11. Sharma P., and Sidorenko E.I. Are screening and surveillance for Barrett's oesophagus really worthwhile?. Gut 54 Suppl 1 (2005) i27-i32
12. Inadomi J.M., Sampliner R., Lagergren J., et al. Screening and surveillance for Barrett's esophagus in high-risk populations: a cost-utility analysis. Ann Intern Med 138 (2003) 176-186
13. Corley D.A., Levin T.R., Habe N.S., et al. Surveillance and survival in Barrett's adenocarcinoma: a population-based study. Gastroenterology 122 (2002) 633-640
14. O'Connor J.B., Falk G.W., and Richter J.E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 94 (1999) 2037-2042
15. Drewitz D.J., Sampliner R.E., and Garewal H.S. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 48 years. Am J Gastroenterol 92 (1997) 212-215
16. Macdonald C.E., Wicks A.C., and Playford R.J. Final results from 10 year cohort of patients undergoing surveillance for Barrett's Oesophagus: observational study. BMJ 321 (2000) 1252-1255
17. Gopal D.V., Lieberman D.A., Magaret N., et al. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Dig Dis Sci 48 (2003) 1537-1541
18. Gray M.R., Donnelly R.J., and Kingsnorth A.N. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut 34 (1993) 727-731
19. Gammon M.D., Schoenberg J.B., Ahsan H., et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89 (1997) 1277-1284
20. Hirota W.K., Loughney T.M., Lazas D.J., et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 116 (1999) 277-285
21. Weston A.P., Krmpotich P.T., Cherian R., et al. Prospective long-term endoscopic and histologic follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol 92 (1997) 407-413
22. de Jonge P.J.F., Steyerberg E.W., Kuipers E.J., et al. Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 202 (2006) 1421-1429
23. El-Serag H.B., Aguirre T.V., Davis S., et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol 99 (2004) 1877-1883
24. Brown L.M., Swanson C.A., Gridley G., et al. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 87 (1995) 104-109
25. Chow W.H., Blot W.J., Vaughan T.L., et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 90 (1998) 150-155
26. Dulai G.S., Guha S., Kahn K.L., et al. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 122 (2002) 26-33
27. Gerson L.B., Shetler K., and Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123 2 (2002) 461-467
28. Ronkainen J., Aro P., Storskrubb T., et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129 6 (2005) 2101-2103
29. Spechler S.J. Intestinal metaplasia at the gastroesophageal junction. Gastroenterology 126 (2004) 567-575
30. Cameron A.J., Souto E.O., Smyrk T.C., et al. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia. Am J Gastroenterol 97 (2002) 1375-1380
31. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's Esophagus with dysplasia. N Engl J Med 360 (2009) 2277-2288
32. Chandrasoma P., Wickramasinghe K., Ma Y., and DeMeester T. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?. Dis Esophagus 20 (2007) 36-41
33. Graham D.Y., and Yamaoka Y.H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter 3 (1998) 145-151
34. Weston A.P., Badr A.S., and Hassanein R.S. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 94 12 (1999) 3413-3419
35. Rubenstein J.H., Sonnenberg A., Davis J., et al. Effect of a prior endoscopy on outcome of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc 68 (2008) 849-855